Nonclinical Pharmacokinetics, Disposition, and Drug-Drug Interaction Potential of a Novel d-Amino Acid Peptide Agonist of the Calcium-Sensing Receptor AMG 416 (Etelcalcetide)
Raju Subramanian(Gilead Sciences (United States)), Gary L. Skiles, Xiaochun Zhu(Amgen (United States)), Savannah J. Kerr(Amgen (United States)), Sarah F. Wilson(Amgen (United States)), Roger Pham(Amgen (United States)), Sarah Walter(UC San Diego Health System), Mylo Wagner(Amgen (United States)), Marcus Soto(Amgen (United States)), Katheryne Z. Edson(Amgen (United States)), Steven W. Louie(Amgen (United States)), Joel Esmay(Amgen (United States))
Cited by 41
Related Papers
Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease
|Nature Communications|2020|539
Predicting Alzheimer’s disease progression using multi-modal deep learning approach
|Scientific Reports|2019|401
Basal forebrain degeneration precedes and predicts the cortical spread of Alzheimer’s pathology
|Nature Communications|2016|349
Glucuronidation of Statins in Animals and Humans: A Novel Mechanism of Statin Lactonization
|Drug Metabolism and Disposition|2002|346
Effects of Fibrates on Metabolism of Statins in Human Hepatocytes
|Drug Metabolism and Disposition|2002|325